These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 20301115

  • 1. Does MC1R genotype convey information about melanoma risk beyond risk phenotypes?
    Kanetsky PA, Panossian S, Elder DE, Guerry D, Ming ME, Schuchter L, Rebbeck TR.
    Cancer; 2010 May 15; 116(10):2416-28. PubMed ID: 20301115
    [Abstract] [Full Text] [Related]

  • 2. Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study.
    Fargnoli MC, Altobelli E, Keller G, Chimenti S, Höfler H, Peris K.
    Melanoma Res; 2006 Apr 15; 16(2):175-82. PubMed ID: 16567973
    [Abstract] [Full Text] [Related]

  • 3. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
    Landi MT, Kanetsky PA, Tsang S, Gold B, Munroe D, Rebbeck T, Swoyer J, Ter-Minassian M, Hedayati M, Grossman L, Goldstein AM, Calista D, Pfeiffer RM.
    J Natl Cancer Inst; 2005 Jul 06; 97(13):998-1007. PubMed ID: 15998953
    [Abstract] [Full Text] [Related]

  • 4. High naevus count and MC1R red hair alleles contribute synergistically to increased melanoma risk.
    Duffy DL, Lee KJ, Jagirdar K, Pflugfelder A, Stark MS, McMeniman EK, Soyer HP, Sturm RA.
    Br J Dermatol; 2019 Nov 06; 181(5):1009-1016. PubMed ID: 30820946
    [Abstract] [Full Text] [Related]

  • 5. MC1R genotype as a predictor of early-onset melanoma, compared with self-reported and physician-measured traditional risk factors: an Australian case-control-family study.
    Cust AE, Goumas C, Vuong K, Davies JR, Barrett JH, Holland EA, Schmid H, Agha-Hamilton C, Armstrong BK, Kefford RF, Aitken JF, Giles GG, Bishop D, Newton-Bishop JA, Hopper JL, Mann GJ, Jenkins MA.
    BMC Cancer; 2013 Sep 04; 13():406. PubMed ID: 24134749
    [Abstract] [Full Text] [Related]

  • 6. Inherited variation at MC1R and histological characteristics of primary melanoma.
    Taylor NJ, Busam KJ, From L, Groben PA, Anton-Culver H, Cust AE, Begg CB, Dwyer T, Gallagher RP, Gruber SB, Orlow I, Rosso S, Thomas NE, Zanetti R, Rebbeck TR, Berwick M, Kanetsky PA.
    PLoS One; 2015 Sep 04; 10(3):e0119920. PubMed ID: 25790105
    [Abstract] [Full Text] [Related]

  • 7. The determinants of periorbital skin ageing in participants of a melanoma case-control study in the U.K.
    Suppa M, Elliott F, Mikeljevic JS, Mukasa Y, Chan M, Leake S, Karpavicius B, Haynes S, Bakker E, Peris K, Barrett JH, Bishop DT, Newton Bishop JA.
    Br J Dermatol; 2011 Nov 04; 165(5):1011-21. PubMed ID: 21787368
    [Abstract] [Full Text] [Related]

  • 8. p53 codon 72 Pro homozygosity increases the risk of cutaneous melanoma in individuals with dark skin complexion and among noncarriers of melanocortin 1 receptor red hair variants.
    Stefanaki I, Stratigos AJ, Dimisianos G, Nikolaou V, Papadopoulos O, Polydorou D, Gogas H, Tsoutsos D, Panagiotou P, Kanavakis E, Antoniou C, Katsambas AD.
    Br J Dermatol; 2007 Feb 04; 156(2):357-62. PubMed ID: 17223878
    [Abstract] [Full Text] [Related]

  • 9. Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries.
    Goldstein AM, Chaudru V, Ghiorzo P, Badenas C, Malvehy J, Pastorino L, Laud K, Hulley B, Avril MF, Puig-Butille JA, Miniere A, Marti R, Chompret A, Cuellar F, Kolm I, Mila M, Tucker MA, Demenais F, Bianchi-Scarra G, Puig S, de-Paillerets BB.
    Int J Cancer; 2007 Aug 15; 121(4):825-31. PubMed ID: 17397031
    [Abstract] [Full Text] [Related]

  • 10. Assessment of polymorphic variants in the melanocortin-1 receptor gene with cutaneous pigmentation using an evolutionary approach.
    Kanetsky PA, Ge F, Najarian D, Swoyer J, Panossian S, Schuchter L, Holmes R, Guerry D, Rebbeck TR.
    Cancer Epidemiol Biomarkers Prev; 2004 May 15; 13(5):808-19. PubMed ID: 15159314
    [Abstract] [Full Text] [Related]

  • 11. Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.
    Demenais F, Mohamdi H, Chaudru V, Goldstein AM, Newton Bishop JA, Bishop DT, Kanetsky PA, Hayward NK, Gillanders E, Elder DE, Avril MF, Azizi E, van Belle P, Bergman W, Bianchi-Scarrà G, Bressac-de Paillerets B, Calista D, Carrera C, Hansson J, Harland M, Hogg D, Höiom V, Holland EA, Ingvar C, Landi MT, Lang JM, Mackie RM, Mann GJ, Ming ME, Njauw CJ, Olsson H, Palmer J, Pastorino L, Puig S, Randerson-Moor J, Stark M, Tsao H, Tucker MA, van der Velden P, Yang XR, Gruis N, Melanoma Genetics Consortium.
    J Natl Cancer Inst; 2010 Oct 20; 102(20):1568-83. PubMed ID: 20876876
    [Abstract] [Full Text] [Related]

  • 12. Host phenotype characteristics and MC1R in relation to early-onset basal cell carcinoma.
    Ferrucci LM, Cartmel B, Molinaro AM, Gordon PB, Leffell DJ, Bale AE, Mayne ST.
    J Invest Dermatol; 2012 Apr 20; 132(4):1272-9. PubMed ID: 22158557
    [Abstract] [Full Text] [Related]

  • 13. Association of Incident Amelanotic Melanoma With Phenotypic Characteristics, MC1R Status, and Prior Amelanotic Melanoma.
    Vernali S, Waxweiler WT, Dillon PM, Kanetsky PA, Orlow I, Luo L, Busam KJ, Kricker A, Armstrong BK, Anton-Culver H, Gruber SB, Gallagher RP, Zanetti R, Rosso S, Sacchetto L, Dwyer T, Cust AE, Ollila DW, Begg CB, Berwick M, Thomas NE, GEM Study Group.
    JAMA Dermatol; 2017 Oct 01; 153(10):1026-1031. PubMed ID: 28746718
    [Abstract] [Full Text] [Related]

  • 14. Contributions by MC1R Variants to Melanoma Risk in Males and Females.
    Wendt J, Mueller C, Rauscher S, Fae I, Fischer G, Okamoto I.
    JAMA Dermatol; 2018 Jul 01; 154(7):789-795. PubMed ID: 29898205
    [Abstract] [Full Text] [Related]

  • 15. MC1R variants increase risk of melanomas harboring BRAF mutations.
    Fargnoli MC, Pike K, Pfeiffer RM, Tsang S, Rozenblum E, Munroe DJ, Golubeva Y, Calista D, Seidenari S, Massi D, Carli P, Bauer J, Elder DE, Bastian BC, Peris K, Landi MT.
    J Invest Dermatol; 2008 Oct 01; 128(10):2485-90. PubMed ID: 18368129
    [Abstract] [Full Text] [Related]

  • 16. Main pigmentary features and melanocortin 1 receptor (MC1R) gene polymorphisms in the population of the Canary Islands.
    de-Misa RF, Pérez-Méndez LI, Hernández-Jiménez JG, Rodríguez Mdel C, Vilar MC, Suárez J, Claveríe-Martín F.
    Int J Dermatol; 2008 Aug 01; 47(8):806-11. PubMed ID: 18717860
    [Abstract] [Full Text] [Related]

  • 17. Phenotypic and histologic characteristics of cutaneous melanoma in patients with melanocortin-1 receptor polymorphisms.
    Avilés JA, Lázaro P, Fernández LP, Benítez J, Ibarrola-Villava M, Ribas G.
    Actas Dermosifiliogr; 2012 Jan 01; 103(1):44-50. PubMed ID: 22464597
    [Abstract] [Full Text] [Related]

  • 18. Melanocortin 1 receptor variants and skin cancer risk.
    Han J, Kraft P, Colditz GA, Wong J, Hunter DJ.
    Int J Cancer; 2006 Oct 15; 119(8):1976-84. PubMed ID: 16721784
    [Abstract] [Full Text] [Related]

  • 19. Interaction between p53 codon 72 polymorphism and melanocortin 1 receptor variants on suntan response and cutaneous melanoma risk.
    Nan H, Qureshi AA, Hunter DJ, Han J.
    Br J Dermatol; 2008 Aug 15; 159(2):314-21. PubMed ID: 18510673
    [Abstract] [Full Text] [Related]

  • 20. MC1R genotype may modify the effect of sun exposure on melanoma risk in the GEM study.
    Kricker A, Armstrong BK, Goumas C, Kanetsky P, Gallagher RP, Begg CB, Millikan RC, Dwyer T, Rosso S, Marrett LD, Thomas NE, Berwick M, GEM Study Group.
    Cancer Causes Control; 2010 Dec 15; 21(12):2137-47. PubMed ID: 20721616
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.